[Federal Register Volume 90, Number 61 (Tuesday, April 1, 2025)]
[Notices]
[Pages 14359-14362]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-05513]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
International Trade Administration
[A-570-836]
Glycine From the People's Republic of China: Notice of
Preliminary Results of Antidumping Duty Changed Circumstances Review
AGENCY: Enforcement and Compliance, International Trade Administration,
Department of Commerce.
SUMMARY: The U.S. Department of Commerce (Commerce) is issuing the
preliminary results of the changed circumstances review (CCR) of the
antidumping duty order on glycine from the People's Republic of China
(China). Commerce preliminarily finds that Salvi Chemical Industries
Limited (Salvi) is eligible to participate in an established
certification process. We invite interested parties to comment on these
preliminary results.
DATES: Applicable April 1, 2025.
FOR FURTHER INFORMATION CONTACT: Tyler Weinhold, AD/CVD Operations,
Office VI, Enforcement and Compliance, International Trade
Administration, U.S. Department of Commerce, 1401 Constitution Avenue
NW, Washington, DC 20230; telephone: (202) 482-1121.
SUPPLEMENTARY INFORMATION:
Background
On March 29, 1995, Commerce published the China Order in the
Federal Register.\1\ On December 10, 2012, Commerce published an
affirmative determination of circumvention of the Order, finding that
glycine processed in India by Salvi using Chinese-origin inputs (e.g.,
crude or technical-grade glycine), and exported to the United States
from India is circumventing the China Order.\2\ Commerce affirmed its
preliminary determination \3\ that the processing of Chinese-origin
technical-grade or crude glycine, including but not limited to AAA-
97TE, ACAA-97TE, sodium glycinate and glycine slurry, is not
substantially transformed into glycine of Indian-origin, and therefore
such glycine remains within the scope of the China Order.\4\ In its
Glycine China Circumvention Final, Commerce instituted a countrywide
certification mechanism for all imports of glycine from India, to
ensure that the inquiry merchandise does not enter the United States as
glycine from India.\5\ Commerce adopted the certification requirement
to ensure that merchandise meeting this scope clarification is properly
identified as merchandise subject to the China Order.\6\ Commerce
applied this certification to all imports of glycine from India, with
the exception of certain companies, including Salvi, because Commerce
determined that glycine produced by Salvi was circumventing the China
Order, and therefore subject to the rates established for glycine from
China.\7\
---------------------------------------------------------------------------
\1\ See Antidumping Duty Order: Glycine from the People's
Republic of China, 60 FR 16116 (March 29, 1995) (China Order).
\2\ See Glycine from the People's Republic of China: Final
Partial Affirmative Determination of Circumvention of the
Antidumping Duty Order, 77 FR at 73426, 73427 (December 10, 2012)
(Glycine China Circumvention Final).
\3\ See Glycine from the People's Republic of China: Preliminary
Partial Affirmative Determination of Circumvention of the
Antidumping Duty Order and Initiation of Scope Inquiry, 77 FR 21533,
21535 (April 10, 2012) (Glycine China Circumvention Prelim).
\4\ See Glycine China Circumvention Final.
\5\ Id., 77 FR at 73426-27.
\6\ Id.
\7\ Id.
---------------------------------------------------------------------------
Salvi requested that Commerce conduct a CCR pursuant to section
751(b) of the Tariff Act of 1930, as amended, (the Act), and 19 CFR
351.216(b), asserting that Commerce: (1) should permit Salvi to
participate in the certification process; (2) should determine that
glycine produced by Salvi is not produced from Chinese-origin raw
material; and, (3) should not subject Salvi's glycine to cash deposit
requirements under the Glycine China Circumvention Final.\8\ Salvi
claims that the raw materials it used to produce glycine in recent
years \9\ have been produced from non-glycine inputs which are outside
the scope of the China Order, irrespective of origin.\10\ Moreover,
Salvi claims that all of the raw materials it used to produce glycine
in recent years have been procured from Indian sources.\11\ Commerce
initiated this CCR, pursuant to the Act and 19 CFR 351.216(d), upon
finding that there is sufficient information to warrant a CCR.\12\
---------------------------------------------------------------------------
\8\ Id.
\9\ In Salvi's CCR Request, Salvi provided evidence relevant to
fiscal years 2021-2021 and 2022-2023 to demonstrate the raw
materials Salvi sourced to produce glycine sold during fiscal year
2022-2023 were solely sourced from Indian origin raw materials. See
Salvi's Letter, ``Request for Changed Circumstances Review,'' dated
April 10, 2024 (Salvi's CCR Request) at 6 and Exhibits 6-9; see also
Salvi's Letter, ``Response to Supplemental Questionnaire,'' dated
January 15, 2025 (Salvi 2SQR) at Exhibits 28 and 28.1 (showing
Indian-produced, non-glycine inputs from suppliers in India).
\10\ See Salvi's CCR Request at 4-6.
\11\ Id. at 6-8.
\12\ See Glycine from the People's Republic of China: Initiation
of Changed Circumstances Review, 89 FR 58104 (July 17, 2024).
---------------------------------------------------------------------------
We issued supplemental questionnaires to Salvi between November
2024 and January 2025,\13\ to which Salvi timely responded.\14\ Deer
Park Glycine, LLC (DPG), a domestic glycine producer, submitted
comments regarding Salvi's supplemental questionnaire responses in
January and February 2025.\15\
---------------------------------------------------------------------------
\13\ See Commerce's Letters, ``Supplemental Questionnaire,''
dated November 14, 2024 (Salvi 1SQ); ``Second Supplemental
Questionnaire,'' dated January 2, 2025 (Salvi 2SQ); and ``Third
Supplemental Questionnaire,'' dated January 29, 2024 (Salvi 3SQ).
\14\ See Salvi's Letters, ``Response to Supplemental
Questionnaire,'' dated December 19, 2024 (Salvi 1SQR); Salvi 2SQR;
and ``Response to Third Supplemental Questionnaire,'' February 12,
2025 (Salvi 3SQR).
\15\ See Petitioner's Letter, ``DPG Comments on Salvi
Supplemental Questionnaire Response,'' dated January 3, 2025; see
also Petitioner's Letter, ``DPG Comments on Salvi's January 15, 2025
Supplemental Questionnaire Response,'' dated January 27, 2025;
Petitioner's Letter, ``DPG Comments on Salvi's January 31, 2025
Response to Petitioner Comments of January 27, 2025,'' dated
February 7, 2025; and Petitioner's Letter, ``DPG Comments on Salvi's
February 12, 2025 Response to Petitioner to the Department's 3rd
Supplemental Questionnaire,'' dated February 28, 2025.
---------------------------------------------------------------------------
Scope of the Order
The product covered by the Order is glycine, which is a free-
flowing crystalline material, like salt or sugar. Glycine is produced
at varying levels of purity and is used as a sweetener/taste enhancer,
a buffering agent, reabsorbable amino acid, chemical intermediate, and
a metal complexing agent. This order covers glycine of all purity
levels. Glycine is currently classified under subheading 2922.49.4020
of the Harmonized Tariff Schedule of the United States (HTSUS).\16\
Although the HTSUS
[[Page 14360]]
subheading is provided for convenience and customs purposes, the
written description of the merchandise under the Order is dispositive.
---------------------------------------------------------------------------
\16\ In separate scope rulings, Commerce determined that: (a)
D(-) Phenylglycine Ethyl Dane Salt is outside the scope of the Order
and (b) Chinese glycine exported from India remains the same class
or kind of merchandise as the China-origin glycine imported into
India. See Notice of Scope Rulings and Anticircumvention Inquiries,
62 FR 62288 (November 21, 1997); see also Glycine China
Circumvention Final.
---------------------------------------------------------------------------
Scope of the Final Circumvention Determination 17
---------------------------------------------------------------------------
\17\ See Glycine China Circumvention Final, 77 FR at 73426.
---------------------------------------------------------------------------
The product covered by Glycine China Circumvention Final was
glycine, as described in the ``Scope of the Order'' section, above,
which is exported from India, but processed using Chinese-origin inputs
(e.g., crude or technical-grade glycine). The Glycine China
Circumvention Final covers glycine produced by certain companies,
including Salvi. Salvi has stated on the record that it also self-
produced glycine from Indian-origin inputs. The focus of the Glycine
China Circumvention Final was to determine whether glycine exported
from India is: (1) produced from inputs manufactured in China; (2)
processed by certain companies, including Salvi in India; and (3) then
exported to the United States as Indian-origin glycine, constituting
circumvention of the China Order under section 781(b) of the Act.
Analysis
Salvi claimed that it produced glycine during fiscal years 2021-
2022 and 2022-2023 using only Indian-origin inputs, and has not
exported glycine to the United States which was processed nor produced
using Chinese-origin inputs (e.g., crude or technical-grade
glycine).\18\ In order to determine whether Salvi's claims were
accurate, and to determine whether Salvi has the ability to make such a
determination, including maintaining sufficient records in the ordinary
course of business, we requested information about Salvi's sales, any
affiliated suppliers of glycine inputs, glycine production processes,
and other business records with respect to its 2021-2022 and 2022-2023
fiscal years.\19\ We requested that Salvi identify all glycine sales
(including export and domestic sales) and all of the purchases of
inputs used to produce the subject glycine that it sold to all markets,
on a sale-by-sale basis.\20\ We also requested that Salvi include
inputs used to produce intermediate products that Salvi may have
produced, and then further processed, before eventually selling the
associated subject glycine finished products.\21\ In addition, we
reviewed and reconciled Salvi's financial statements and information
from Salvi's accounting systems to the reported domestic and import
purchase and sales registers.\22\ Further, to confirm the overall
accuracy of the information Salvi provided, we also requested documents
related to specific sales and purchase transactions which we
selected.\23\ Salvi complied with our requests and provided the
requested information.\24\
---------------------------------------------------------------------------
\18\ See, e.g., Salvi's CCR Request at 4-6.
\19\ See Salvi 1SQ at 4-11; see also Salvi 2SQ at 4-6; and Salvi
3SQ at 4-5.
\20\ Id.
\21\ See Salvi 1SQ at 4-5; see also Salvi 3SQ at 4.
\22\ See Salvi's CCR Request at 5-8, Exhibits 6-9, 11, and 12;
see also Salvi 1SQR at 2-4, Exhibits 13, 13.1, 14.1, 14.2, 14.3, 21,
21.1, and 22; Salvi 2SQR at 2-5, Exhibits 28, 28.1, 29, 30, 30.1, 32
and 34; and Salvi 3SQR at 5, Exhibits 35 and 35.1.
\23\ See Salvi's CCR Request at 6 and Exhibit 10; see also Salvi
1SQR at 7-9, Exhibits 21, 21.2, and 22; Salvi 2SQ at 5-6, and
Exhibit 33; and Salvi 3SQR at 3 and Exhibit 36.
\24\ See Salvi 1SQR at 1-13; see also Salvi 2SQR at 2-8; and
Salvi 3SQR at 1-4.
---------------------------------------------------------------------------
Based on the information provided by Salvi, we preliminarily find
that Salvi has demonstrated that it has eliminated the use of Chinese
inputs from its production process, and that Salvi records, and is able
to identify, the origin of the inputs used to produce glycine. Further,
Salvi is able to track the origin of these inputs through its
production processes of glycine and track it to the final glycine it
sells.\25\ Accordingly, because of the elimination of the use of
Chinese inputs in its production process, not solely Salvi's ability to
track the origin of its inputs through to non-U.S. sales, we
preliminarily determine that Salvi is eligible to participate in the
certification process established in Glycine China Circumvention Final.
---------------------------------------------------------------------------
\25\ See Salvi's CCR Request at 5-8, Exhibits 6-12; see also
Salvi 1SQR at 2-13, Exhibits 13-14.3, 21-22; Salvi 2SQR at 2-8,
Exhibits 28-30, 30.1, 32-34; and Salvi 3SQR at 1-5, Exhibits 35 and
35.1.
---------------------------------------------------------------------------
If these preliminary results are adopted in the final results,
effective on the publication date of our final results, Salvi, its
downstream exporters, and its importers will be eligible, where
appropriate, to certify that glycine produced by Salvi in India and
exported from India was not processed from Chinese-origin glycine
(e.g., crude or technical-grade glycine) or other Chinese-origin raw
material inputs. Glycine entering the United States with such
certification will not be subject to suspension of liquidation and a
requirement to post cash deposits of estimated antidumping duties
associated with the China Order. However, glycine entering the United
States with such certification will be subject to suspension of
liquidation and cash deposits related to the India Order.\26\ The draft
certification language is attached as an appendix to this notice.
Interested parties are invited to comment on the draft certification
language in their case briefs.
---------------------------------------------------------------------------
\26\ See Glycine from India and Japan: Amended Final Affirmative
Antidumping Duty Determination and Antidumping Duty Orders, 84 FR
29170 (June 21, 2019) (India Order).
---------------------------------------------------------------------------
Certification Requirements
In accordance with 19 CFR 351.225(l)(3), the notice of suspension
of liquidation and of the certification requirements for entries of
glycine produced in India using Chinese-origin glycine inputs (e.g.,
crude or technical-grade glycine) or other Chinese-origin raw material
inputs occurred with the publication of the Glycine China Circumvention
Final.\27\ If the final results of this CCR remain unchanged from the
preliminary results, glycine produced by Salvi in India using non-
glycine inputs or using non-Chinese-origin inputs (e.g., crude or
technical-grade glycine) and subsequently exported to in the United
States, will no longer be subject to the China Order, as the subject
glycine sourced and produced by Salvi in India is of Indian origin.
However, imports of such merchandise will remain subject to the
certification requirements, and cash deposits applicable to glycine
from China may be required if the certification requirements are not
satisfied. Accordingly, if an importer enters glycine produced by Salvi
in India, and claims that the subject glycine was produced in India
using inputs of non-Chinese-origin, in order not to be subject to cash
deposit requirements the importer and exporter are required to meet the
certification and documentation requirements described in the
certification.\28\ Where no certification is provided for an entry of
subject glycine produced by Salvi in India and exported from India to
the United States, the China Order will apply to that entry and
Commerce intends to instruct CBP to collect cash
[[Page 14361]]
deposits of estimated antidumping duties equal to the cash deposit
rates established for entries of subject merchandise from China.\29\
---------------------------------------------------------------------------
\27\ See Glycine China Circumvention Final, 77 FR at 73426; see
also U.S. Customs and Border Protection (CBP) Message 2353309,
``Final Affirmative Determination of Circumvention of the
Antidumping Duty Order on Glycine from the People's Republic of
China (A-570-836/A-533-975),'' dated December 18, 2012 (CBP Message
2353309); and CBP Message 2270302, ``Preliminary Scope Determination
Antidumping Duty Order on Glycine from the People's Republic of
China (China) that is Processed in India (A-570-836 and A-533-
975),'' dated September 26, 2012 (CBP Message 2270302).
\28\ See Glycine China Circumvention Final, 77 FR at 73426 at
``Scope Ruling;'' see also CBP Message number 2270302, dated
September 29, 2012.
\29\ See Glycine China Circumvention Final, 77 FR at 73426-27;
see also Glycine China Circumvention Prelim, 77 FR at 21533; CBP
Message 2270302; CBP Message 2353309; and China Order, 60 FR at
16116.
---------------------------------------------------------------------------
For shipments and/or entry summaries made on or after the date of
publication of the initiation of the CCR through 30 days after the date
of publication of the final results of this CCR for which
certifications are required, importers and exporters should complete
the required certification within 45 days after the publication of the
final results of this CCR in the Federal Register. Accordingly, where
appropriate, the relevant item in the certification should be modified
to reflect that the certification was completed within the time frame
specified above. For such entries/shipments, importers and exporters
each have the option to complete a blanket certification covering
multiple entries/shipments, individual certifications for each entry/
shipment, or a combination thereof. For shipments and/or entries made
on or after 31 days after the date of publication of the final results
of this CCR in the Federal Register, for which certifications are
required, importers should complete the required certification at or
prior to the date of entry summary, and exporters should complete the
required certification and provide it to the importer at or prior to
the date of shipment.
Public Comment
Pursuant to 19 CFR 351.309(c)(1)(ii), interested parties may submit
case briefs to Commerce no later than seven days after the publication
of this notice. Rebuttal briefs, limited to issues raised in case
briefs, may be filed not later than five days after the date for filing
case briefs.\30\ All comments are to be filed electronically using
Antidumping and Countervailing Duty Centralized Electronic Service
System (ACCESS). An electronically filed document must be received
successfully in its entirety by ACCESS by 5:00 p.m. Eastern Time on the
established deadline.\31\
---------------------------------------------------------------------------
\30\ See 19 CFR 351.309(d).
\31\ See 19 CFR 351.303(b).
---------------------------------------------------------------------------
As provided under 19 CFR 351.309(c)(2) and (d)(2), in prior
proceedings we have encouraged interested parties to provide an
executive summary of their brief that should be limited to five pages
total, including footnotes. In this CCR, we instead request that
interested parties provide at the beginning of their briefs a public,
executive summary for each issue raised in their briefs.\32\ Further,
we request that interested parties limit their executive summary of
each issue to no more than 450 words, not including citations. We
intend to use the executive summaries as the basis of the comment
summaries included in the issues and decision memorandum that will
accompany the final results in this CCR. We request that the interested
parties include footnotes for relevant citations in the executive
summary of each issue. Note that Commerce has amended certain of its
requirements pertaining to the service of documents in 19 CFR
351.303(f).
---------------------------------------------------------------------------
\32\ We use the term ``issue'' here to describe an argument that
Commerce would normally address in a comment of the Issues and
Decision Memorandum.
---------------------------------------------------------------------------
Pursuant to 19 CFR 351.310(c), interested parties who wish to
request a hearing must submit a written request to the Assistant
Secretary for Enforcement and Compliance, filed electronically via
ACCESS. Requests should contain: (1) the party's name, address, and
telephone number; (2) the number of participants; and (3) a list of the
issues to be discussed. Issues raised in the hearing will be limited to
those raised in the respective case briefs. An electronically filed
hearing request must be received successfully in its entirety by
Commerce's electronic record system, ACCESS, by 5:00 p.m. Eastern Time
within seven days after the date of publication of this notice. Oral
presentations at the hearing will be limited to issues raised in the
briefs. If a request for a hearing is made, parties will be notified of
the time and date for the hearing, in accordance with 19 CFR
351.310(d).
Consistent with 19 CFR 351.216(e), we intend to issue the final
results of this CCR no later than 270 days after the date on which
these reviews were initiated, or within 45 days after the publication
of the preliminary results if all parties in this CCR agree to our
preliminary results. This notice is published in accordance with
sections 751(b)(1) and 777(i) of the Act and 19 CFR 351.216(b),
351.221(b) and 351.221(c)(3).
Notifications to Interested Parties
We are issuing and publishing this notice of preliminary results in
accordance with sections 751(b)(1) and 777(i) of the Act, 19 CFR
351.216, and 19 CFR 351.221(c)(3)(i).
Dated: March 25, 2025.
Christopher Abbott,
Deputy Assistant Secretary for Policy and Negotiations, performing the
non-exclusive functions and duties of the Assistant Secretary for
Enforcement and Compliance.
Appendix--Certification
Importer Certification
I hereby certify that:
A. My name is {IMPORTING COMPANY OFFICIAL'S NAME{time} and I am
an official of {IMPORTING COMPANY{time} , located at {ADDRESS OF
IMPORTING COMPANY{time} .
B. I have direct personal knowledge of the facts regarding the
importation into the Customs territory of the United States of the
glycine (e.g., crude or technical-grade glycine) in India that
entered under entry summary number(s), identified below, and are
covered by this certification. ``Direct personal knowledge'' refers
to facts the certifying party is expected to have in its own
records. For example, the importer should have direct personal
knowledge of the importation of PRODUCT, including the exporter's
and/or foreign seller's identity and location.
C. If the importer is acting on behalf of the first U.S.
customer, include the following sentence as paragraph C of this
certification:
The glycine (e.g., crude or technical-grade glycine) covered by
this certification was imported by {IMPORTING COMPANY{time} on
behalf of {U.S. CUSTOMER{time} , located at {ADDRESS OF U.S.
CUSTOMER{time} .
If the importer is not acting on behalf of the first U.S.
customer, include the following sentence as paragraph C of this
certification:
{NAME OF IMPORTING COMPANY{time} is not acting on behalf of the
first U.S. customer.
D. The glycine e.g., crude or technical-grade glycine covered by
this certification were shipped to {NAME OF PARTY IN THE UNITED
STATES TO WHOM THE MERCHANDISE WAS FIRST SHIPPED{time} , located at
{U.S. ADDRESS TO WHICH MERCHANDISE WAS SHIPPED{time} .
E. I have personal knowledge of the facts regarding the
production of the imported products covered by this certification.
``Personal knowledge'' includes facts obtained from another party,
(e.g., correspondence received by the importer (or exporter) from
the producer regarding the source of the inputs used to produce the
imported products).
F. This certification applies to the following entries (repeat
this block as many times as necessary):
Entry Summary #:
Entry Summary Line Item #:
Foreign Seller:
Foreign Seller's Address:
Foreign Seller's Invoice #:
Foreign Seller's Invoice Line Item #:
Country of Origin of glycine (e.g., crude or technical-grade
glycine) and non-glycine inputs to produce glycine:
Producer:
Producer's Address:
G. The glycine (e.g., crude or technical-grade glycine) covered
by this certification does not contain glycine nor non-glycine
[[Page 14362]]
inputs produced in the People's Republic of China (China) or of
Chinese origin.
H. I understand that {IMPORTING COMPANY{time} is required to
maintain a copy of this certification and sufficient documentation
supporting this certification (i.e., documents maintained in the
normal course of business, or documents obtained by the certifying
party, for example, laboratory reports, certificates of origin,
product data sheets, mill test reports, productions records,
purchase invoices, certificate of origin, etc.) until the later of
(1) the date that is five years after the latest entry date of the
entries covered by the certification or (2) the date that is three
years after the conclusion of any litigation in the United States
courts regarding such entries.
I. I understand that {IMPORTING COMPANY{time} is required to
maintain a copy of the exporter's certification (attesting to the
production and/or exportation of the imported merchandise identified
above), and any supporting documentation provided to the importer by
the exporter, until the later of (1) the date that is five years
after the latest entry date of the entries covered by the
certification or (2) the date that is three years after the
conclusion of any litigation in United States courts regarding such
entries.
J. I understand that {IMPORTING COMPANY{time} is required to
provide U.S. Customs and Border Protection (CBP) and/or the U.S.
Department of Commerce (Commerce) with the importer certification,
and any supporting documentation, and a copy of the exporter's
certification, and any supporting documentation provided to the
importer by the exporter, upon request of either agency.
K. I understand that the claims made herein, and the
substantiating documentation, are subject to verification by CBP
and/or Commerce.
L. I understand that failure to maintain the required
certification and supporting documentation, or failure to
substantiate the claims made herein, or not allowing CBP and/or
Commerce to verify the claims made herein, may result in a de facto
determination that all entries to which this certification applies
are within the scope of the ANTIDUMPING DUTY (AD) ORDERS on glycine
(e.g., crude or technical-grade glycine) from China. I understand
that such finding will result in:
(i) suspension of liquidation of all unliquidated entries (and
entries for which liquidation has not become final) for which these
requirements were not met;
(ii) the importer being required to post the ANTIDUMPING duty
cash deposits determined by Commerce; and
(iii) the importer no longer being allowed to participate in the
certification process.
M. I understand that agents of the importer, such as brokers,
are not permitted to make this certification.
N. This certification was completed by the time of filing the
entry summary or within 45 days of the date on which Commerce
published notice of its final changed circumstances review findings
in the Federal Register.
O. I am aware that U.S. law (including, but not limited to, 18
U.S.C. 1001) imposes criminal sanctions on individuals who knowingly
and willfully make material false statements to the U.S. government.
Signature
{NAME OF COMPANY OFFICIAL{time}
{TITLE OF COMPANY OFFICIAL{time}
{DATE{time}
Exporter Certification
The party that made the sale to the United States should fill
out the exporter certification.
I hereby certify that:
A. My name is {COMPANY OFFICIAL'S NAME{time} and I am an
official of {NAME OF FOREIGN COMPANY THAT MADE THE SALE TO THE
UNITED STATES{time} , located at {ADDRESS OF FOREIGN COMPANY THAT
MADE THE SALE TO THE UNITED STATES{time} .
B. I have direct personal knowledge of the facts regarding the
production and exportation of the glycine (e.g., crude or technical-
grade glycine) for which sales are identified below. ``Direct
personal knowledge'' refers to facts the certifying party is
expected to have in its own records. For example, an exporter should
have direct personal knowledge of the producer's identity and
location.
C. The glycine (e.g., crude or technical-grade glycine) covered
by this certification were shipped to {NAME OF PARTY IN THE UNITED
STATES TO WHOM MERCHANDISE WAS FIRST SHIPPED{time} , located at
{U.S. ADDRESS TO WHICH MERCHANDISE WAS SHIPPED{time} .
D. The glycine (e.g., crude or technical-grade glycine) covered
by this certification does not contain glycine nor non-glycine
inputs produced in the People's Republic of China (China),
regardless of whether sourced directly from a Chinese producer or
from a downstream seller.
E. This certification applies to the following sales to {NAME OF
U.S. CUSTOMER{time} , located at {ADDRESS OF U.S. CUSTOMER{time}
(repeat this block as many times as necessary):
Foreign Seller's Invoice # to U.S. Customer:
Foreign Seller's Invoice to U.S. Customer Line item #:
Producer Name:
Producer's Address:
Producer's Invoice # to Foreign Seller: (State ``N/A'' if the
foreign seller and the producer are the same party)
Name of Producer of glycine (technical glycine, etc.) and non-
glycine inputs to produce glycine: (State ``N/A'' if the producer
did not use glycine (technical glycine, etc.) and non-glycine inputs
in the production of glycine)
Location (Country) of Producer of glycine (technical glycine, etc.)
and non-glycine inputs: (State ``N/A'' if the producer did not use
glycine (technical glycine, etc.) and non-glycine inputs in the
production of glycine)
F. I understand that {NAME OF FOREIGN COMPANY THAT MADE THE SALE
TO THE UNITED STATES{time} is required to maintain a copy of this
certification and sufficient documentation supporting this
certification (i.e., documents maintained in the normal course of
business, or documents obtained by the certifying party, for
example, laboratory reports, certificates of analysis, mill test
reports, productions records, purchase invoices, certificate of
origin, etc.) until the later of: (1) the date that is five years
after the latest date of the entries covered by the certification;
or (2) the date that is three years after the conclusion of any
litigation in the United States courts regarding such entries.
G. I understand that {NAME OF FOREIGN COMPANY THAT MADE THE SALE
TO THE UNITED STATES{time} is required to provide the U.S. importer
with a copy of this certification and is required to provide U.S.
Customs and Border Protection (CBP) and/or the U.S. Department of
Commerce (Commerce) with this certification, and any supporting
documents, upon request of either agency.
H. I understand that the claims made herein, and the
substantiating documentation, are subject to verification by CBP
and/or Commerce.
I. I understand that failure to maintain the required
certification and supporting documentation, or failure to
substantiate the claims made herein, or not allowing CBP and/or
Commerce to verify the claims made herein, may result in a de facto
determination that all sales to which this certification applies are
within the scope of the ANTIDUMPING DUTY orders on glycine (e.g.,
crude or technical-grade glycine) from China. I understand that such
a finding will result in:
(i) suspension of all unliquidated entries (and entries for
which liquidation has not become final) for which these requirements
were not met;
(ii) the importer being required to post the ANTIDUMPING DUTY
cash deposits determined by Commerce; and
(iii) the seller/exporter no longer being allowed to participate
in the certification process.
J. I understand that agents of the seller/exporter, such as
freight forwarding companies or brokers, are not permitted to make
this certification.
K. This certification was completed at time of shipment or
within 45 days of the date on which Commerce published notice of its
final changed circumstances review findings in the Federal Register.
L. I am aware that U.S. law (including, but not limited to, 18
U.S.C. 1001) imposes criminal sanctions on individuals who knowingly
and willfully make material false statements to the U.S. government.
Signature
{NAME OF COMPANY OFFICIAL{time}
{TITLE OF COMPANY OFFICIAL{time}
{DATE{time}
[FR Doc. 2025-05513 Filed 3-31-25; 8:45 am]
BILLING CODE 3510-DS-P